Home Tags Fresenius

Tag: Fresenius

Popular Articles

SK Capital seals $1bn-plus sale of Niacet to food major Kerry Group

0
Specialty materials, chemicals and pharma-focused investment house SK Capital Partners has agreed to sell Niacet to food major Kerry Group in a deal worth more than $1bn.

Thoma Bravo’s Hudson Smith reveals how to pick winners amid the scramble for pharmaceutical...

0
The Covid-19 crisis has pushed what was already a healthy pharmaceutical investment market into overdrive, especially for tech and software-related deals. Fresh from his firm's buyout of clinical trial finance software provider Greenphire, Thoma Bravo partner Hudson Smith explained to AltAssets how to navigate the sector's high prices and where firms need to be aiming to get the best returns.

Intera Partners draws increased European LP interest to hit €335m hard cap Fund IV...

0
Intera Partners has hit a €335m hard cap close for its latest fund targeting the capital gap in Finland's lower mid-market.

BDC spinout Amplitude hits C$200m target to close ‘precision medicine’ fund

0
BDC spinout Amplitude Venture Capital has hit its C$200m target for the final close of its debut fund targeting Canadian healthcare companies.

‘Rising star’ Kate Wallman promoted to managing director at Encore Consumer Capital

0
Sector specialist private equity player Encore Consumer Capital has promoted Kate Wallman to managing director after five years with the firm.

EQT seals $9.6bn sale of Covid vaccine DNA supplier Aldevron, less than two years...

0
Private equity major EQT has agreed a $9.6bn sale of vaccine DNA and mRNA supplier Aldevron to Danaher Corp, just two years after buying into the business.

CarVal soars past hard cap for new distressed fundraise to hit $3.6bn final close

0
Distressed and credit-intensive asset-focused CarVal Investors has hauled in $3.6bn for its latest Credit Value Fund, exceeding its hard cap by 20%.

HQ Capital collects $210m to beat target for second co-investment fundraise

0
HQ Capital has beaten its target for its second co-investment fundraise by reaching a $210m final close.

Biggest-ever private database investment sees Neo4j valuation soar past $2bn

0
The biggest investment ever made in a private database business has seen Neo4j’s valuation soar to more than $2bn.

TA sells majority stake in investment data management specialist Confluence to Clearlake Capital

0
TA Associates has sold a majority stake in investment industry software and data specialist Confluence Technologies to fellow private equity house Clearlake Capital.

Get the latest PE News & Research delivered to your inbox every morning